KRENAVA Trademark

Trademark Overview


On Wednesday, October 21, 2015, a trademark application was filed for KRENAVA with the United States Patent and Trademark Office. The USPTO has given the KRENAVA trademark a serial number of 79180956. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 23, 2022. This trademark is owned by Novartis AG. The KRENAVA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-inf...
krenava

General Information


Serial Number79180956
Word MarkKRENAVA
Filing DateWednesday, October 21, 2015
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 23, 2022
Registration Number4971226
Registration DateTuesday, June 7, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 22, 2016

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral preparations and antibiotics

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 23, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Wednesday, August 23, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, December 23, 2022CANCELLED SECTION 71
Thursday, January 26, 2017INTERNATIONAL REGISTRATION RENEWED
Friday, December 9, 2016NOTIFICATION PROCESSED BY IB
Friday, July 8, 2016FINAL DISPOSITION NOTICE SENT TO IB
Friday, July 8, 2016FINAL DISPOSITION PROCESSED
Thursday, July 7, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, June 7, 2016REGISTERED-PRINCIPAL REGISTER
Tuesday, March 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, March 2, 2016NOTICE OF PUBLICATION
Friday, February 5, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, February 5, 2016ASSIGNED TO EXAMINER
Tuesday, February 2, 2016APPLICATION FILING RECEIPT MAILED
Thursday, January 28, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 22, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, January 21, 2016SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB